Please provide your email address to receive an email when new articles are posted on . Tisagenlecleucel is increasingly used as earlier treatment for younger patients with B-cell acute lymphoblastic ...

“The advancement of novel therapies like CAR-T in relapsed and refractory pediatric B-ALL is truly a beacon of hope for children and young adults with a previously dismal prognosis.” Following the ...

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, "The price of hope: CAR-T therapy in pediatric leukemia." Following the pivotal ELIANA trial, tisa-cel was ...

Each year, around 4,000 children are living with leukemia, according to Children’s Hospital of Philadelphia. The outlook for kids with this cancer has improved dramatically over the years, thanks in ...